Appearing earlier a Senate committee Thursday, the CEOs of Johnson and Johnson, Merck and Bristol Myers Squibb answered questions arsenic to wherefore the terms of their drugs are 3 times higher successful the U.S. than successful 33 different affluent countries. Scott MacFarlane has more.